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httpcense.Abstract Background: COPD is a multi-system disorder. It appears to be associated with the pres-
ence of systemic inﬂammatory markers as C reactive protein.
Aim of the work: The present study aimed to evaluate the brain-stem auditory evoked potentials
(BAEP) abnormalities in stable COPD patient and its correlation with high sensitivity C reactive
protein (hs-CRP) as a part of multi-system disorder.
Subjects and methods: This case control study was carried out at Mansoura University Hospital
Egypt from October 2009 to February 2010. The study comprised 40 stable COPD patients and 15
healthy controls with no risk that may lead to neuropathy. All the patients and controls were sub-
jected to the following: I-Thorough history taking and clinical examination. II-Pulmonary function
tests including: 1-Spirometry 2-Body plethsymography 3-Arterial blood gases analysis. III- Record
of brain-stem auditory evoked potentials (BAEP) including: latencies of waves I, II, III, IV and V
together with interpeak latencies (IPLs) of I–III, I–V and III–V and amplitudes of waves I–Ia and
V–Va. IV – Measurement of serum high sensitivity C reactive protein (hs-CRP) by ELISA tech-
nique. V – Statistical analysis.
Results: The level of hs-CRP reactive protein in COPD was signiﬁcantly elevated and correlated
with spirometric, blood gases parameters and GOLD stage. The BAEP latencies of waves I, II, III,
IV and V, together with interpeak latencies and amplitudes of waves I–Ia and V–Va measured on
both ears were signiﬁcantly different in COPD patients than controls. The prevalence of brain-stem
auditory evoked potentials abnormalities was higher among very severe group of COPD. Most of
BAEP wave latencies together with interpeak latencies and wave amplitudes on both ears were sig-
niﬁcantly correlated with the spirometric and blood gases parameters. The level of hs-CRP was cor-
related signiﬁcantly with abnormalities of BAEP variables.27931334.
. Shalabi).
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Figure 1 Brainstem auditory evoke
Prolonged I–V interpeak latency on t
314 N. Shalabi et al.Conclusion: This study showed signiﬁcant subclinical BAEP abnormalities in studied stable
COPD male patients. This indicates conductive defect of auditory nerve, cochlea and even hearing
pathway in the brain as a part of systemic inﬂammation.
Theses BAEP abnormalities were signiﬁcantly correlated with GOLD classiﬁcation, hs-CRP and
PaO2.
ª 2012 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
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Chronic obstructive pulmonary disease (COPD) is a disease
state characterized by airﬂow limitation that is not fully revers-
ible. The airﬂow limitation is usually progressive and associ-
ated with an abnormal inﬂammatory response of the lung to
noxious particles or gases [1] (see Fig. 1).
COPD is presently regarded as multi-system disorder. It is
associated with peripheral neuropathy, motor neuron involve-
ment, encephalopathy and derangement of cognitive function [2].
Brain-stem auditory evoked potentials (BAEP) are the
potentials recorded from the ear and vertex in response to a
brief auditory stimulation to assess the conduction through
auditory nerve, cochlea and hearing pathway in brain [3].
C-reactive protein (CRP) is an acute-phase protein synthe-
sized predominantly by hepatocytes in response to tissue dam-
age or inﬂammation. It reﬂects the total systemic burden of
inﬂammation of individuals and has been shown to be increased
in COPD in stable condition and during exacerbation [4].
Aim of the work
The present study aimed to evaluate the brain-stem auditory
evoked potentials (BAEP) abnormalities in stable COPD pa-
tient and its correlation with high sensitivity C reactive protein
(hs-CRP) as a part of multi-system disorder.
Subjects and methods
This case control study was carried out in Thoracic Medicine
Department, Neurology Department and Clinical Pathology
Department at Mansoura University Hospital Egypt. Alld potentials wave pattern over r
he right side and prolonged III–subjects were male and enrolled from October 2009 to Febru-
ary 2010. The study comprised two groups. Group I included
40 stable COPD patients. Group II included 15 healthy non
smoker volunteers of age and sex matched with patients group
having no risk that may lead to neuropathy.
Inclusion criteria
The diagnosis of COPD was based on criteria deﬁned in the
Global initiative for chronic obstructive lung disease (GOLD)
2004 guidelines. All the included COPD patients were smokers
and had irreversible/partially reversible obstruction of airﬂow.
The studied subjects were in a clinically stable state.
Exclusion criteria
Patients with clinical evidence of neuropathy, or those with
diabetes mellitus, chronic alcoholism, uremia, cystic ﬁbrosis,
sarcoidosis, leprosy, malignancy, history of intake of any neu-
rotoxic drug, history of traumatic lesion possibly affecting
brain-stem function.
All the patients and control group were subjected to the
following:-
I- Thorough history taking and clinical examination
II- IPulmonary function tests
1- 1-Spirometry using spirometry Jaeger Germany 1998.
We stress on FEV1, FVC, FEV1/FVC ratio and MVV.
2- 2-Body plethysmography using pressure plethysmogra-
phy, air tight chamber body Jaegar Germany 1998 of
kabine type. The value ofRVand total lung capacity TLC.ight ear and left ear of COPD patient with bilateral abnormality.
V latency on the left side.
Table 1 Characteristics of COPD patients group (n= 40) and healthy control group (n= 15).
COPD (n= 40) Control (n= 15) P value
Age (years) 59.87 ± 3.85 58.73 ± 3.81 0.65
Smoking index (Pack years) 53.24 ± 16.60 Nil
FEV1(% of predicted) 45.22 ± 15.96 90.18 ± 5.80 <0.001
FVC (% of predicted) 68.32 ± 6.46 85.22 ± 5.25 <0.001
FEV1/FVC (%) 57.48 ± 10.15 84.78 ± 7.64 <0.001
RV (% of predicted) 159.38 ± 36.10 102.84 ± 1.63 <0.001
TLC (% of predicted) 133.85 ± 15.26 104.28 ± 6.18 <0.001
MVV (% of predicted) 36.43 ± 7.18 104.28 ± 6.18 <0.001
PH 7.37 ± 8.50 7.33 ± 0.05 <0.05
PaO2 (mmHg) 65.79 ± 14.26 84.93 ± 3.20 <0.001
PaCO2 (mmHg) 49.13 ± 8.07 38.33 ± 2.06 <0.001
HCO3 (mEq/L) 31.99 ± 2.89 27.40 ± 0.74 <0.001
hs-CRP (lg/ml) 37.42 ± 17.77 1.86 ± 0.38 <0.001
Signiﬁcant when P 6 0.05. Moderately signiﬁcant when P 6 0.01. Highly signiﬁcant P 6 0.001.
Table 2 Brain-stem auditory evoked potentials (BAEP) vari-
ables in COPD patients and controls.
Left ear COPD (n= 40) Control (n= 15) P value
Latencies
I (ms) 1.97 ± 0.36 1.72 ± 0.13 <0.05
II (ms) 3.12 ± 0.47 3.17 ± 0.28 <0.05
III (ms) 3.97 ± 0.52 3.27 ± 0.16 <0.01
IV (ms) 4.88 ± 52 4.09 ± 0.18 <0.01
V (ms) 4.98 ± 0.51 4.72 ± 0.22 0.29
Interpeak latencies(IPLs)
I–III(ms) 2.14 ± 0.27 2.1 ± 0.14 <0.05
I–V (ms) 4.16 ± 0.47 3.63 ± 0.24 <0.01
III–V (ms) 1.84 ± 0.36 2.12 ± 39 <0.01
Amplitudes
I–Ia (lv) 0.38 ± 0.28 0.64 ± 072 <0.001
V–Va (lv) 0.43 ± 0.58 0.49 ± 0.15 <0.001
Right ear
Latencies
I (ms) 1.73 ± 0.41 1.42 ± 0.13 <0.05
II (ms) 2.90 ± 0.46 3.17 ± 0.28 <0.01
III (ms) 4.21 ± 0.54 3.37 ± 0.16 <0.001
IV (ms) 4.74 ± 0.61 4.09 ± 0.18 <0.001
V (ms) 6.00 ± 0.59 4.72 ± 0.22 <0.001
Interpeak latencies(IPLs)
I–III (ms) 2.35 ± 0.36 1.87 ± 0.15 <0.05
I–V (ms) 4.39 ± 0.29 3.73 ± 0.18 <0.01
III–V (ms) 2.14 ± 0.32 1.84 ± 0.13 <0.01
Amplitudes
I–Ia (lv) 0.25 ± 0.12 0.39 ± 0.25 <0.001
V–Va (lv) 0.35 ± 0.35 0.49 ± 0.14 <0.001
Signiﬁcant when P 6 0.05. Moderately signiﬁcant when P 6 0.01.
Highly signiﬁcant P 6 0.001.
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III- Procedure of brain-stem auditory evoked potentials
(BAEP)The apparatus used was NIHON KOHDEN,
Neuropack MEP 9400 series EMG IEP measuring
system.
1- Absolute latency:
It was measured from the stimulus artifact to the peak (the
point of the maximum deﬂection) of each of the waves ana-lyzed and expressed in millisecond (msec). The absolute la-
tency of the waves I, II, III, IV, and V were measured.
1- Interpeak latency: I–III, III–V, and I–V.
2- I/V amplitude ratio:
The amplitude of wave I was divided by the amplitude of
the wave V. The wave I amplitude was measured from the
highest part of the wave I to the bottom of the trough of I.
The wave V amplitude was measured from the highest point
of the wave V to the trough of V.
I- Measurement of high sensitivity C reactive protein
(hs-CRP):From every patients and control, 2 ml of
venous blood sample were taken in a plain vaccutain-
er tube, centrifuged at 3000 rpm after 15 min and the
sera were rapidly separated and stored in eppendorf
tubes at 70 C until the time of assay. High sensitiv-
ity C reactive protein (hs-CRP) was determined in the
sera of patients and controls using enzyme linked
immunosorbent assay (ELISA) technique. We used
commercially available kits from Accubind (USA).
The assays were done following the manufacturer’s
instructions.
II- Statistical analysisData was analyzed using SPSS
(Statistical Package for Social Sciences) version 14.
Quantitative data was tested for normality by Kolomogrov-
Smirov test. Normally distributed data was presented
as mean ± SD. Student t-test was used to compare
between two groups. Pearson’s correlation co-efﬁcient
was used to test correlation between variables.
Results
Subject characteristics
We included 55 male subjects comprising 40 COPD patients
and age matched 15 healthy volunteers. The indices of spirom-
etry and blood gases of COPD patients were signiﬁcantly dif-
ferent from control. The serum level of hs-C reactive protein in
COPD patients was signiﬁcantly elevated (Table 1).
316 N. Shalabi et al.Brain-stem auditory evoked potentials (BAEP) variables in
COPD patients and controls over left and right ear
Over left ear, the latencies of waves I, II, III, and IV were sig-
niﬁcantly increased in COPD patients (Table 2). Over the right
ear the latencies of waves I, II, III, IV and V were signiﬁcantly
increased in COPD patients. The interpeak latencies (IPLs) of
I–III, I–V and III–V together with the amplitude of the waves
I–Ia and V–Va were signiﬁcantly different in COPD on both
left and right ears (Table 2).
Prevalence of brain-stem auditory evoked potentials (BAEP)
abnormalities according to GOLD classiﬁcation of COPD
patients
The number and percent of COPD patients with brain-stem
auditory evoked potentials abnormalities was more prevalent
among very severe COPD on both left and right ears (Table 3).
Correlation of hs-C reactive protein with characteristics of
COPD patients
The hs-C reactive protein showed signiﬁcant positive correla-
tion with smoking index, GOLD stage, TLC and RV. On
the other hand there was negative signiﬁcant correlation with
FEV1, FVC and PaO2 (Table 4).
Correlation of brain-stem auditory evoked potentials (BAEP)
variables with smoking index, and spirometric indices on both
ears
On the left ear the latencies of wave I of BAEP showed signif-
icant negative correlation with FEV1 and FVC. On the other
hand it showed signiﬁcant positive correlation with RV and
TLC. The latencies of wave III and V showed signiﬁcant neg-
ative correlation with FEV1. The latencies of wave IV showed
signiﬁcant negative correlation with FEV1/FVC (Table 5).
On the right ear latencies of wave I of BAEP showed signif-
icant negative correlation with FEV1, FVC and signiﬁcant po-
sitive correlation with smoking index, TLC. The latencies of
wave III and V showed signiﬁcant negative correlation with
FEV1, FEV1/FVC and signiﬁcant positive correlation with
RV (Table 7).
All the interpeak latencies together with amplitude of waves
were signiﬁcantly correlated with smoking index, and spiro-
metric indices on both ears (Tables 5 and 7).
Correlation of brain-stem auditory evoked potentials (BAEP)
variables with blood gases and hs-C reactive protein on both ears
BAEP waves I, II, III, IV and V of both ears together with
interpeak latencies showed signiﬁcant positive correlation with
hs-CRP on both ears. On the other hand, wave amplitudes
showed signiﬁcant negative correlation with hs-CRP (Tables
6 and 8).
BAEP wave I showed signiﬁcant positive correlation with
PaCO2 and signiﬁcant negative correlation with PaO2 on both
ears (Tables 6 and 8). BAEP wave III, IV showed signiﬁcant
positive correlation with PaCO2 and signiﬁcant negative corre-
lation with PaO2 on both ears (Tables 6 and 8). BAEP wave Von left ear correlated signiﬁcantly and negatively with PaO2
(Table 6). The interpeak latencies showed signiﬁcant positive
correlation with PaCO2 and signiﬁcant negative correlation
with PaO2 on both ears. The wave amplitude of BAEP on both
ears showed signiﬁcant negative correlation with PaCO2 and
signiﬁcant positive correlation with PaO2 on both ears (Tables
6 and 8).Discussion
Although COPD affects the lung, it also produces signiﬁcant
systemic consequences. The consequences can be detected clin-
ically and appear to be associated with the presence of systemic
inﬂammatory markers [5].
In our study, we included stable COPD with moderate,
severe and very severe airway obstruction with no clinical
evidence of any neuropathy. Our aim was to evaluate the
brain-stem auditory evoked potentials (BAEP) abnormalities
in stable COPD patient and its correlation with high sensitiv-
ity C-reactive protein (hs-CRP) as a part of multi-system
disorder.
Gan and Co-workers [6] were the ﬁrst to note the impor-
tance of high CRP levels in COPD patients. They showed that
hs-CRP is elevated in patient who actively smoked. Broekhui-
zen et al. [7] found that hs-CRP was a marker of impaired
energy metabolism, functional capacity and distress in 102
severe COPD patients. It is widely accepted that CRP levels
relates to the presence of airﬂow obstruction [8].
In the present study hs-CRP level is correlated with spiro-
metric parameters and with Gold classiﬁcation (Table 4).
Miniati et al. [9] found that the level of CRP was correlated
mainly with physiological parameters, such as FEV1, FVC,
TLC, and GOLD stages. Oga et al. [10] showed that as lung
hyperinﬂation worsens, exercise capacity decreases over time.
FEV1 % of predicted is the most important predictor of future
clinical COPD outcomes. After adjustment with or without
matching for FEV1 % of predicted, serum CRP remained a
signiﬁcant predictor of clinical COPD outcomes adding to
the prognostic value of FEV1 in predicting COPD. This cor-
roborates with the idea that airﬂow limitation and airway
inﬂammation are separate and independent factors in patho-
physiology of COPD and suggest that serum CRP predict fu-
ture COPD in individuals with airway obstruction independent
of lung function [11].
High sensitivity CRP is inversely correlated to PaO2 in our
study and this was in agreement with Miniti et al. [9]. Indeed it
is widely accepted that COPD patients with hypoxemia have a
higher mortality which is improved with oxygen therapy. Hyp-
oxemia triggers oxidative stress and inﬂammation in COPD
patients [12].
There is now sufﬁcient evidence to support the presence of
extra pulmonary or systemic consequences of COPD that can
be detected clinically [13] and that could also be measured by
the determination of level of increased systemic inﬂammatory
markers. CRP is one of these markers that could reﬂect the to-
tal systemic burden of inﬂammation [5].
El-Kady et al. [14] found statistically signiﬁcant difference
for all audio-logical measures between the control group and
COPD. The present study showed signiﬁcant prolonged laten-
cies and interpeak latencies with decrease in amplitude on both










Left ear N % N % N % N %
Latencies
I (ms) 2(20.0) 4(26.7) 8(53.5) 14(35.0)
II (ms) 0(0) 1(7.7) 3(20.0) 4(10.0)
III (ms) 1(10.0) 5(33.3) 6(40.0) 12(30.0)
IV (ms) 2(20.0) 3(20.0) 4(26.7) 9(22.5)
V (ms) 1(10.0) 2(13.3) 3(20.0) 6(15.0)
Interpeak latencies(IPLs)
I–III (ms) 2(20.0) 3(20) 4(26.7) 9(22.5)
I–V (ms) 2(20.0) 4(26.7) 5(33.3) 12(30.0)
III–V (ms) 1(10.0) 1(7.7) 3(20.0) 5(12.5)
Amplitudes
I–Ia (lv) 1(10.0) 2(13.3) 3(20.0) 6(15)
V–Va (lv) 2(20.0) 4(26.7) 5(33.3) 11(27.5)
Right ear
Latencies
I (ms) 3(30.0) 3(20.0) 9(60.0) 15(37.5)
II (ms) 1(10.0) 2(13.3) 3(20.0) 6(15.0)
III (ms) 1(10.0) 4(26.7) 5(33.3) 10(25.0)
IV (ms) 3(30.0) 4(26.7) 3(20.0) 10(25.0)
V (ms) 1(10.0) 2(13.3) 3(20.0) 6(15.0)
Interpeak latencies(IPLs)
I–III (ms) 1(10.0) 2(13.3) 5(33.3) 8(20.0)
I–V (ms) 2(20.0) 4(26.7) 5(33.3) 11(27.5)
III–V (ms) 1(10.0) 1(7.7) 2(13.3) 4(10.0)
Amplitudes
I–Ia (lv) 1(10.0) 3(20.0) 4(26.7) 8(40.0)
V–Va (lv) 3(30.0) 4(26.7) 6(40.0) 13(32.5)
Both ears
Latencies
I (ms) 1(10.0) 3(20.0) 5(33.3) 9(22.5)
II(ms) 0(0) 2(13.3) 3(20.0) 5(12.5)
III (ms) 1(10.0) 4(26.7) 5(33.3) 10(25.0)
IV (ms) 2(20.0) 3(20.0) 4(26.7) 9(22.5)
V (ms) 1(10.0) 2(13.3) 3(20.0) 6(15.0)
Interpeak latencies(IPLs)
I–III (ms) 1(10.0) 2(13.3) 4(26.7) 7(17.5)
I–V (ms) 1(10.0) 3(20.0) 3(20.0) 7(17.5)
III–V (ms) 1(10.0) 1(7.7) 2(13.3) 4(10.0)
Amplitudes
I–Ia (lv) 1(10.0) 2(13.3) 3(20.0) 6(15.0)
V–Va (lv) 1(10.0) 3(20.0) 5(33.3) 9(22.5)
Signiﬁcant when P 6 0.05. moderately signiﬁcant when P 6 0.01. Highly signiﬁcant P 6 0.001.
Brain-stem auditory evoked responses in COPD patients 317ears (Table 2). The prevalence of these abnormalities was more
among more severe form of COPD. Gupta et al. [15] observed
the same ﬁnding during study 80 male subjects comprising 40
of COPD patients and 40 ages matched healthy volunteers.
The overall prevalence of these abnormalities in one or more
BAEP is 24/40 (60%). Aties et al. [16] noted BAEP abnormal-
ities in 76.1% of 21 male COPD patients. This higher preva-
lence could be attributed to the fact that COPD included in
this study had clinical evidence of neuropathy.
Sohmer et al. [17] demonstrated depression of the auditory
nerve brain-stem evoked response as well as vestibular and vi-
sual evoked potentials during severe hypoxemia in cats. Inaddition to chronic hypoxemia and hypercapnia, other
associated factors in patients with COPD, including tobacco
smoking, malnutrition and drugs used in COPD treatment,
like long acting inhaled B2 agonists, inhaled anticholinergic
agents, inhaled glucocorticoids, and sustained release theoph-
ylline, may be possibly associated with neuropathy seen in
COPD patients [18]. COPD patients in our study were heavy
smokers (Table 1). The BAEP latency of waves I showed
signiﬁcant positive correlation with smoking index on both
ears ( Tables 5 and 7). Smoking index also, showed
signiﬁcant positive correlation with BAEP latency of waves
IV (Table 7).
Table 4 Correlation of hs-CRP with characteristics of COPD
patients.
COPD characteristics Correlation P-value
Smoking index 0.61 0.00
FEV1% of pred 0.69 0.00
FVC% of pred 0.49 0.00
FEV1/FVC% of pred 0.23 0.13
RV% of pred 0.55 0.00
TLC% of pred 0.56 0.00
GOLD stage 0.17 0.04
PH 0.30 0.84
PaCO2 (mmHg) 0.67 0.00
PaO2 (mmHg) 0.76 0.00
HCO3 (mEq/L) 0.42 0.00
Signiﬁcant when P 6 0.05. Moderately signiﬁcant when P 6 0.01.
Highly signiﬁcant P 6 0.001.
318 N. Shalabi et al.Gupta et al. [15] could not ﬁnd any correlation between
BAEP parameters and indices of pulmonary function test, ex-
cept BAEP latency of waves I and III with FEV1 on left side.
The insigniﬁcant correlation in Gupta’s study was attributed
to the narrow range of patients’ characters and pulmonary
function. BAER wave III latency showed signiﬁcant inverse
correlation with PEFR, FEF25% and FEF25-75%. Interpeak la-
tency (IPL) of BAER I–III was also signiﬁcantly inversely cor-
related with FEV1/FVC and FEF25–75% [19]. In the present
study BAEP latency of waves I, III, and V showed signiﬁcant
negative correlation with FEV1. Also wave I showed signiﬁ-
cant negative correlation with FVC, FEV1/FVC, RV and totalTable 5 Correlation of brain-stem auditory evoked potentials (B
spirometric indices.
Latencies (Lt) Smoking index FEV1% of pred FVC% o
I (ms) r 0.21 0.49 0.4
p 0.17 0.00 0.00
II (ms) r 0.04 0.16 0.24
p 0.8 0.3 0.11
III (ms) r 0.03 0.36 0.1
p 0.87 0.01 0.51
IV (ms) r 0.09 0.15 0.03
p 0.51 0.3 0.81
V (ms) r 0.25 0.28 0.16
p 0.09 0.05 0.28
Interpeak latencies
I–III (ms) r 0.35 0.37 0.3
p 0.01 0.01 0.03
I–V (ms) r 0.56 0.31 0.41
p 0 0.03 0.01
III–V (ms) r 0.34 0.44 0.54
p 0.01 0.00 0.00
Amplitudes
I–Ia (lv) r 0.43 0.29 0.54
p 0.00 0.04 0.00
V–Va (lv) r 0.6 0.39 0.56
p 0.00 0.00 0.00
Signiﬁcant when P 6 0.05. Moderately signiﬁcant when P 6 0.01. Highlylung capacity on the left ear (Table 5). Also, the interpeak la-
tency and amplitude were signiﬁcantly correlated with all spi-
rometric measures. BAEP latency of waves I, III and IV on the
right ear showed signiﬁcant negative correlation with FEV1.
Also wave I and III showed signiﬁcant positive correlation
with RV and TLC on the right ear (Table 7). Airways obstruc-
tion ﬁnally causes changes in arterial blood gases which should
be implicated for the impairment in the nerve conduction in
brain stem causing prolongation in BAER [19].
Shomer et al. [17] showed depression in all BAERs in cats
under severe hypoxemia. As the same depression was also ob-
served when normal blood oxygenation was maintained and
cerebral ischemia was induced, they speculated that the pri-
mary hypoxemia did not affect the ability of the brain tissue
to generate evoked potentials but rather led to a secondary
depression of the cardiovascular system, to cerebral ischemia
and impaired the oxygen supply of the brain. Friss et al. [20]
detected prolongations in BAER wave V and IPL of III–V
in preterm infants under hypercarbic state. They speculated
that hypercarbia had a deleterious effect on neuronal function.
IPL of BAER III–V which represents the central portion of the
auditory pathway was signiﬁcantly correlated with PaCO2 and
HCO3 and pH of the arterial blood gas [19].
The present study COPD patients were free from any neu-
rological abnormalities. They had signiﬁcant lower PaO2,
higher PaCO2 and HCO3 than control (Table 1). BAER laten-
cies of wave I, II, IV and interpeak latencies showed signiﬁcant
negative correlation with PaO2 and signiﬁcant positive correla-
tion with PaCO2 on both ears. Also the amplitudes showed
signiﬁcant positive correlation with PaO2 and signiﬁcant
negative correlation with PaCO2 blood gases on both ears.AEP) variables recorded over left ear with smoking index and





















signiﬁcant P 6 0.001.
Table 7 Correlation of brain-stem auditory evoked potentials (BAEP) variables recorded over right ear with smoking index and
spirometric indices.
Latencies (Rt) Smoking index FEV1% of pred FVC% of pred FEV1/FVC% of pred RV% of pred TLC% of pred
I (ms) r 0.54 0.43 0.45 0.03 0.27 0.41
p 0.00 0.00 0.00 0.83 0.07 0.00
II (ms) r 0.05 0.08 0.06 0.03 0.12 0.02
p 0.73 0.6 0.7 0.98 0.44 0.88
III (ms) r 0.04 0.5 0.94 0.46 0.55 0.26
p 0.77 0 0.53 0.001 0 0.08
IV (ms) r 0.29 0.48 0.23 0.35 0.48 0.37
p 0.05 0 0.13 0.01 0.001 0.01
V (ms) r 0.16 0.14 0.13 0.34 0.23 0.16
p 0.28 0.36 0.38 0.01 0.12 0.3
Interpeak latencies
I–III (ms) r 0.33 0.4 0.43 0.45 0.54 0.32
p 0.03 0.00 0.00 0.00 0.00 0.03
I–V (ms) r 0.49 0.54 0.38 0.35 0.32 0.39
p 0.001 0.00 0.00 0.01 0.03 0.00
III–V (ms) r 0.35 0.32 0.6 0.32 0.38 0.34
p 0.01 0.03 0.00 0.03 0.00 0.01
Amplitudes
I–Ia (lv) r 0.29 0.34 0.42 0.56 0.55 0.59
p 0.04 0.01 0.00 0.00 0.00 0.00
V–Va (lv) r 0.41 0.49 0.41 0.32 0.42 0.37
p 0.00 0.00 0.00 0.03 0.00 0.01
Signiﬁcant when P 6 0.05. Moderately signiﬁcant when P 6 0.01. Highly signiﬁcant P 6 0.001.
Table 6 Correlation of brain-stem auditory evoked potentials (BAEP) variables recorded over left ear with blood gases and hs-CRP.
Latencies (Lt) PH PCO2 (mmHg) PO2 mmHg) HCO3 (mEq/L) Hs-CRP (lg/ml)
I (ms) r 0.07 0.48 0.51 0.39 0.52
p 0.6 0.00 0.00 0.01 0.00
II (ms) r 0.19 0.26 0.33 0.17 0.36
p 0.2 0.08 0.02 0.25 0.01
III (ms) r 0.19 0.39 0.36 0.14 0.28
p 0.21 0.01 0.01 0.33 0.05
IV (ms) r 0.2 0.2 0.33 0.12 0.14
p 0.18 0.18 0.02 0.43 0.36
V (ms) r 0.16 0.26 0.34 0.09 0.49
p 0.27 0.88 0.01 0.52 0.00
Interpeak latencies
I–III (ms) r 0.42 0.33 0.31 0.43 0.29
p 0.00 0.27 0.03 0.003 0.05
I–V (ms) r 0.35 0.49 0.39 0.38 0.57
p 0.02 0.00 0.01 0.01 0.00
III–V (ms) r 0.15 0.07 0.45 0.41 0.47
p 0.33 0.63 0.00 0.01 0.00
Amplitudes
I–Ia (lv) r 0.34 0.38 0.35 0.37 0.41
p 0.02 0.01 0.01 0.01 0.01
V–Va (lv) r 0.35 0.41 0.45 0.49 0.4
p 0.02 0.01 0.00 0.00 0.01
Signiﬁcant when P 6 0.05. Moderately signiﬁcant when P 6 0.01. Highly signiﬁcant P 6 0.001.
Brain-stem auditory evoked responses in COPD patients 319Visual-, auditory-, and somatosensory evoked potentials are
well established neurophysiological tests and are widely used.Al Tahan et al. [21] studied the event related evoked potentials
in chronic respiratory encephalopathy. Their results show
Table 8 Correlation of brain-stem auditory evoked potentials (BAEP) variables recorded over right ear with blood gases and hs-CRP.
Latencies (Rt) PH PCO2 (mmHg) PO2 (mmHg) HCO3 (mEq/L) hs-CRP (lg/ml)
I (ms) r 0.07 0.31 0.27 0.4 0.49
p 0.63 0.03 0.06 0.01 0.00
II(ms) r 0 0.12 0.12 0.19 0.13
p 0.98 0.45 0.44 0.21 0.93
III (ms) r 0.13 0.64 0.66 0.24 0.41
p 0.38 0.00 0.00 0.09 0.00
IV (ms) r 0.24 0.53 0.65 0.29 0.62
p 0.01 0.00 0.00 0.04 0.00
V (ms) r 0.23 0.17 0.17 0.03 0.02
p 0.12 0.24 0.26 0.83 0.88
Interpeak latencies
I–III (ms) r 0.18 0.51 0.62 0.42 0.4
p 0.23 0 0.01 0.00 0.00
I–V (ms) r 0.12 0.56 0.54 0.34 0.29
p 0.43 0.00 0.03 0.02 0.05
III–V (ms) r 0.23 0.31 0.56 0.85 0.39
p 0.12 0.03 0.02 0.00 0.00
Amplitudes
I–Ia (lv) r 0.56 0.54 0.32 0.34 0.41
p 0.00 0.00 0.03 0.02 0.00
V–Va (lv) r 0.51 0.31 0.58 0.38 0.32
p 0.00 0.03 0.00 0.01 0.03
Signiﬁcant when P 6 0.05. Moderately signiﬁcant when P 6 0.01. Highly signiﬁcant P 6 0.001.
320 N. Shalabi et al.signiﬁcant delay of wave latencies in patients with severe and
mild respiratory failure.
Conclusion
This study showed signiﬁcant subclinical BAEP abnormalities
in studied stable COPD male patients. This indicates conduc-
tive defect of auditory nerve, cochlea and even hearing path-
way in the brain as a part of systemic inﬂammation.
Theses BAEP abnormalities were signiﬁcantly correlated
with GOLD classiﬁcation, hs-CRP and PaO2.
Recommendation
COPD patients must undergo periodic evaluation of auditory
function.
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